A Protein-TruncatingHSD17B13Variant and Protection from Chronic Liver Disease-Reference-Cited by-同舟云学术

A Protein-TruncatingHSD17B13Variant and Protection from Chronic Liver Disease

Published:2018-03-22 Issue:12 Volume:378 Page:1096-1106
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Abul-Husn Noura S.¹,Cheng Xiping¹,Li Alexander H.¹,Xin Yurong¹,Schurmann Claudia¹,Stevis Panayiotis¹,Liu Yashu¹,Kozlitina Julia¹,Stender Stefan¹,Wood G. Craig¹,Stepanchick Ann N.¹,Still Matthew D.¹,McCarthy Shane¹,O’Dushlaine Colm¹,Packer Jonathan S.¹,Balasubramanian Suganthi¹,Gosalia Nehal¹,Esopi David¹,Kim Sun Y.¹,Mukherjee Semanti¹,Lopez Alexander E.¹,Fuller Erin D.¹,Penn John¹,Chu Xin¹,Luo Jonathan Z.¹,Mirshahi Uyenlinh L.¹,Carey David J.¹,Still Christopher D.¹,Feldman Michael D.¹,Small Aeron¹,Damrauer Scott M.¹,Rader Daniel J.¹,Zambrowicz Brian¹,Olson William¹,Murphy Andrew J.¹,Borecki Ingrid B.¹,Shuldiner Alan R.¹,Reid Jeffrey G.¹,Overton John D.¹,Yancopoulos George D.¹,Hobbs Helen H.¹,Cohen Jonathan C.¹,Gottesman Omri¹,Teslovich Tanya M.¹,Baras Aris¹,Mirshahi Tooraj¹,Gromada Jesper¹,Dewey Frederick E.¹

Affiliation:

1. From the Regeneron Genetics Center (N.S.A.-H., A.H.L., C.S., S. McCarthy, C.O., J.S.P., S.B., N.G., S. Mukherjee, A.E.L., E.D.F., J.P., I.B.B., A.R.S., J.G.R., J.D.O., O.G., T.M.T., A.B., F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, Y.X., P.S., Y.L., D.E., S.Y.K., B.Z., W.O., A.J.M., G.D.Y., J.G.), Tarrytown, NY; the University of Texas Southwestern Medical Center at Dallas, Dallas (J.K., S.S., H.H.H., J.C.C.); and Geisinger Health System, Danville (G.C.W., A.N.S., M.D.S., X. Chu, J.Z.L., U.L.M., D.J...

Funder

Regeneron Pharmaceuticals

Perelman School of Medicine, University of Pennsylvania

Smilow Foundation

National Institutes of Health

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1712191

Cited by 611 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine;The Journal of Nutritional Biochemistry;2024-11

2. The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease;Genes;2024-09-08

3. Soybean meal peptide Gly-Thr-Tyr-Trp could protect mice from acute alcoholic liver damage: A study of protein-protein interaction and proteomic analysis;Food Chemistry;2024-09

4. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

5. Unveiling the Multifaceted Role of CIDEB: From Apoptosis to Lipid Metabolism and Liver Health;Livers;2024-08-27